These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 12611582)

  • 1. Percutaneous isolated hepatic perfusion for chemotherapy: a phase 1 study.
    Savier E; Azoulay D; Huguet E; Lokiec F; Gil-Delgado M; Bismuth H
    Arch Surg; 2003 Mar; 138(3):325-32. PubMed ID: 12611582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolated hepatic perfusion for unresectable hepatic metastases from colorectal cancer.
    Bartlett DL; Libutti SK; Figg WD; Fraker DL; Alexander HR
    Surgery; 2001 Feb; 129(2):176-87. PubMed ID: 11174711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolated hepatic perfusion for the treatment of patients with colorectal cancer liver metastases after irinotecan-based therapy.
    Alexander HR; Libutti SK; Pingpank JF; Bartlett DL; Helsabeck C; Beresneva T
    Ann Surg Oncol; 2005 Feb; 12(2):138-44. PubMed ID: 15827794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolated hepatic perfusion with high-dose melphalan for the treatment of colorectal metastasis confined to the liver.
    Rothbarth J; Pijl ME; Vahrmeijer AL; Hartgrink HH; Tijl FG; Kuppen PJ; Tollenaar RA; van de Velde CJ
    Br J Surg; 2003 Nov; 90(11):1391-7. PubMed ID: 14598420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolated hypoxic hepatic perfusion with retrograde outflow in patients with irresectable liver metastases; a new simplified technique in isolated hepatic perfusion.
    Verhoef C; de Wilt JH; Brunstein F; Marinelli AW; van Etten B; Vermaas M; Guetens G; de Boeck G; de Bruijn EA; Eggermont AM
    Ann Surg Oncol; 2008 May; 15(5):1367-74. PubMed ID: 18239976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delivery of anticancer drugs via isolated hepatic perfusion: a promising strategy in the treatment of irresectable liver metastases?
    Vahrmeijer AL; Van Der Eb MM; Van Dierendonck JH; Kuppen PJ; Van De Velde CJ
    Semin Surg Oncol; 1998; 14(3):262-8. PubMed ID: 9548610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome analysis of a decade-long experience of isolated hepatic perfusion for unresectable liver metastases at a single institution.
    Magge D; Choudry HA; Zeh HJ; Cunningham DE; Steel J; Holtzman MP; Jones HL; Pingpank JF; Bartlett DL; Zureikat AH
    Ann Surg; 2014 May; 259(5):953-9. PubMed ID: 24169176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolated hepatic perfusion with oxaliplatin combined with 100 mg melphalan in patients with metastases confined to the liver: A phase I study.
    van Iersel LB; de Leede EM; Vahrmeijer AL; Tijl FG; den Hartigh J; Kuppen PJ; Hartgrink HH; Gelderblom H; Nortier JW; Tollenaar RA; van de Velde CJ
    Eur J Surg Oncol; 2014 Nov; 40(11):1557-63. PubMed ID: 25125340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of isolated nonresectable liver metastases in colorectal cancer patients: a case-control study of isolated hepatic perfusion with melphalan versus systemic chemotherapy.
    van Iersel LBJ; Koopman M; van de Velde CJH; Mol L; van Persijn van Meerten EL; Hartgrink HH; Kuppen PJK; Vahrmeijer AL; Nortier JWR; Tollenaar RAEM; Punt C; Gelderblom H
    Ann Oncol; 2010 Aug; 21(8):1662-1667. PubMed ID: 20110289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic vascular isolation and perfusion for patients with progressive unresectable liver metastases from colorectal carcinoma refractory to previous systemic and regional chemotherapy.
    Alexander HR; Libutti SK; Bartlett DL; Pingpank JF; Kranda K; Helsabeck C; Beresnev T
    Cancer; 2002 Aug; 95(4):730-6. PubMed ID: 12209715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolated hepatic perfusion as a treatment for liver metastases of uveal melanoma.
    Ben-Shabat I; Hansson C; Sternby Eilard M; Cahlin C; Rizell M; Lindnér P; Mattsson J; Olofsson Bagge R
    J Vis Exp; 2015 Jan; (95):52490. PubMed ID: 25650893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolated hepatic perfusion for liver metastases of malignant melanoma.
    Rizell M; Mattson J; Cahlin C; Hafström L; Lindner P; Olausson M
    Melanoma Res; 2008 Apr; 18(2):120-6. PubMed ID: 18337648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase I/II studies of isolated hepatic perfusion with mitomycin C or melphalan in patients with colorectal cancer hepatic metastases.
    Marinelli A; Vahrmeijer AL; van de Velde CJ
    Recent Results Cancer Res; 1998; 147():83-94. PubMed ID: 9670271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase I study of hyperthermic isolated hepatic perfusion with oxaliplatin in the treatment of unresectable liver metastases from colorectal cancer.
    Zeh HJ; Brown CK; Holtzman MP; Egorin MJ; Holleran JL; Potter DM; Bartlett DL
    Ann Surg Oncol; 2009 Feb; 16(2):385-94. PubMed ID: 19034580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolated hepatic perfusion for the treatment of colorectal metastases confined to the liver: recent trends and perspectives.
    Rothbarth J; Tollenaar RA; Schellens JH; Nortier JW; Kool LJ; Kuppen PJ; Mulder GJ; van de Velde CJ
    Eur J Cancer; 2004 Aug; 40(12):1812-24. PubMed ID: 15288282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolated hypoxic hepatic perfusion with orthograde or retrograde flow in patients with irresectable liver metastases using percutaneous balloon catheter techniques: a phase I and II study.
    van Etten B; Brunstein F; van IJken MG; Marinelli AW; Verhoef C; van der Sijp JR; Guetens G; de Boeck G; de Bruijn EA; de Wilt JH; Eggermont AM
    Ann Surg Oncol; 2004 Jun; 11(6):598-605. PubMed ID: 15172933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolated hepatic perfusion with extracorporeal oxygenation using hyperthermia, tumour necrosis factor alpha and melphalan.
    Lindnér P; Fjälling M; Hafström L; Kierulff-Nielsen H; Mattsson J; Scherstén T; Rizell M; Naredi P
    Eur J Surg Oncol; 1999 Apr; 25(2):179-85. PubMed ID: 10218462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Percutaneous isolated hepatic perfusion (chemosaturation) with melphalan following right hemihepatectomy in patients with cholangiocarcinoma and metastatic uveal melanoma: peri- and post-interventional adverse events and therapy response compared to a matched group without prior liver surgery.
    Dewald CLA; Becker LS; Maschke SK; Meine TC; Alten TA; Kirstein MM; Vogel A; Wacker FK; Meyer BC; Hinrichs JB
    Clin Exp Metastasis; 2020 Dec; 37(6):683-692. PubMed ID: 33034815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolated hepatic perfusion chemotherapy for unresectable malignant hepatic tumors.
    Ku Y; Tominaga M; Iwasaki T; Fukumoto T; Kuroda Y
    Int J Clin Oncol; 2002 Apr; 7(2):82-90. PubMed ID: 12018114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased local cytostatic drug exposure by isolated hepatic perfusion: a phase I clinical and pharmacologic evaluation of treatment with high dose melphalan in patients with colorectal cancer confined to the liver.
    Vahrmeijer AL; van Dierendonck JH; Keizer HJ; Beijnen JH; Tollenaar RA; Pijl ME; Marinelli A; Kuppen PJ; van Bockel JH; Mulder GJ; van de Velde CJ
    Br J Cancer; 2000 May; 82(9):1539-46. PubMed ID: 10789721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.